Roy A. Beveridge, M.D.

Senior Vice President and Chief Medical Officer, Humana

Watch the Transform 2013 Collide discussion panel.

Roy A. Beveridge, M.D., joined Humana in June 2013 as senior vice president and chief medical officer. He is responsible for developing and implementing Humana's clinical strategy, with an emphasis on advancing the company's integrated care delivery model, especially in the areas of quality and cost improvement. He reports directly to the president and chief executive officer and is a member of the executive team, which sets the strategic direction for the company.

Previously, Dr. Beveridge served as chief medical officer for McKesson Specialty Health, a Dallas-based subsidiary of McKesson Inc. Prior to McKesson's acquisition of US Oncology in 2010, he served as the executive vice president and medical director at US Oncology. Dr. Beveridge also was the co-director of the Bone Marrow Transplant Program at Inova Fairfax Hospital in Falls Church, Va.

Dr. Beveridge earned a Bachelor of Arts degree from Johns Hopkins University and a medical degree from Cornell University Medical College. He completed his residency in internal medicine at University of Chicago Hospitals and his fellowship at Johns Hopkins Hospital.

Board certified in medical oncology and internal medicine, Dr. Beveridge has authored numerous articles on a wide range of medical topics such as hematology, stem cell transplantation, quality and value-based medical practice.

Dr. Beveridge is a member of the MedFusion board of directors, the American Society of Clinical Oncology and the American Society of Hematology. Previously, he has served on the boards of the American Cancer Society and the National Patient Advocate Foundation.

Oct. 16, 2013